-174 G/C polymorphism of interleukin 6 gene in women with type 1 diabetes;Polimorfismo -174 G/C del gen promotor de interleuquina 6 en mujeres con diabetes mellitus tipo 1

Revista Medica de Chile

Volumn 139, Issue 2, 2011, Pages 158-164

  Pérez Bravo, Francisco ^a   Francisca Soto, M ^a   Patricia Lopez A ^b   Francisca Eyzaguirre, C ^b   Codner, Ethel ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Body mass index; Diabetes mellitus; Interleukin 6; Type 1

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHILD; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PRESCHOOL CHILD; WEIGHT GAIN;

ADOLESCENT; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; WEIGHT GAIN; YOUNG ADULT;

EID: 79957638326     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872011000200003     Document Type: Article

References (31)

1. Dabelea D. The accelerating epidemic of childhood diabetes. The Lancet 2009; 373: 1999-2000.
2. Mehers KL, Gillespie KM The genetic basis for type 1 diabetes. Br Med Bull 2008; 88: 115-29.
3. Merriman TR. Type 1 diabetes, the A1 milk hypothesis and vitamin D deficiency. Diabetes Res Clin Pract 2009; 83: 149-56.
4. TEDDY Study Group, The environmental determinants of diabetes in the young (TEDDY) study, Ann NY Acad Sci 2008; 1150: 1-13.
5. Pang TT, Narendran P. Addressing insulin resistance in Type 1 diabetes. Diab Med 2008; 25: 1015-24.
6. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009; 5: 219-26.
7. Codner E. Estrogen and type 1 diabetes mellitus. Pediatr Endocrinol Rev 2008; 6: 228-34.
8. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002; 13: 357-68.
9. Vozarova B, Weyer C, Hanson K, Tatarani P, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin actino, and insulin secretion. Obes Res 2001; 9: 414-7.
10. Kern Pa, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis facor and IL-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280: E745-E751.
11. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, et al. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338-42.
12. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-34.
13. Qi L, Zhang C, van Dam RM, Hu FB. Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab 2007; 92: 3618-25.
14. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102: 1369-76.
15. Jahromi MM, Millward BA, Demaine AG. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res 2000; 20: 885-8.
16. Gillespie KM, Nolsoe R, Betin V, Kristiansen OP, Bingley PJ, Mandrup-Poulsen T, et al. Is Puberty an accelerator of type 1 Diabetes in IL6-174CC Females? Diabetes 2005; 54: 1245-8.
17. Kristiansen OP, Nolsoe RL, Larsen L, Gjesing AM, Johannesen J, Larsen ZM, et al. Association of a functional 17 b-estradiol sensitive IL6-174G/C promoter polymorphism whit early-onset type 1 diabetes in females. Human Molecular Genetics 2003; 12: 1101-10.
18. Ogden CL, Kuczmarski JR, Flegal KM, Mei Z, Guo S, Wei R, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109: 45-60.
19. Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: the good, the bad, or the indifferent?. Diabetes 2005; 54: S114-24.
20. Raunio T, Knuuttila M, Hiltunen L, Karttunen R, Vainio O, Tervonen T. IL-6(-174) genotype associated with the extent of periodontal disease in type 1 diabetic subjects. J Clin Periodontol 2009; 36: 11-7.
21. Myliwiec M, Myliwska J, Zorena K, Balcerska A, Malinowska E, Winiewski P. Interleukin 6-174(G>C) gene polymorphism is related to celiac disease and autoimmune thyroiditis coincidence in diabetes type 1 children. Diabetes Res Clin Pract 2008; 82: 108-12.
22. Lim CS, Zheng S, Kim YS, Ahn C, Han JS, Kim S, et al. The-174 G to C polymorphism of interleukin-6 gene is very rare in koreans. Cytokine 2002; 19: 52-4.
23. Zhai R, Liu G, Yang C, Huang C, Wu C, Christiani DC. The G to C polymorphism at-174 of the interleukin-6 gene is rare in a Southern Chinese population. Pharmacogenetics 2001; 8: 699-701.
24. Hermann C, Krikovszky D, Füst G, Kovács M, Körner A, Szabó A, et al. Association between interleukin-6 polymorphism and age-at-onset of type 1 diabetes. Epistatic influences of the tumor necrosis factor-alpha and interleukin-1 beta polymorphisms. Eur Cytokine Netw 2005; 16: 277-81.
25. Hamid YH, Rose CS, Urhammer SA, Glümer C, Nolsøe R, Kristiansen OP, et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 2005; 48: 251-60.
26. Wernstedt I, Eriksson AL, Berndtsson A, Hoffstedt J, Skrtic S, Hedner T, et al. A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes Relat Metab Disord 2004; 28: 1272-9.
27. Di Renzo L, Bertoli A, Bigioni M, Del Gobbo V, Premrov MG, Calabrese V, et al. Body composition and-174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Curr Pharm Des 2008; 14: 2699-706.
28. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001; 22: 2243-52.
29. Eklund C, Nenonen A, Kukkonen-Harjula K, Borg P, Fogelholm M, Laine S, et al. Association of the IL6-174(G/C) polymorphism with C-reactive protein concentration after weight loss in obese men. Eur Cytokine Netw 2006; 17: 131-5.
30. Guzmán-Guzmán IP, Muñoz-Valle JF, Flores-Alfaro E, Salgado-Goytia L, Salgado-Bernabé AB, Parra-Rojas I. Interleukin-6 gene promoter polymorphisms and cardiovascular risk factors. A family study. Dis Markers 2010; 28: 29-36.
31. Vural P, Deǧirmencioǧlu S, Saral NY, Akgül C. Tumor necrosis factor alpha (-308), interleukin-6 (-174) and interleukin-10 (-1082) gene polymorphisms in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2010; 150: 61-5.